[An adult case of bacterial meningitis caused by penicillin-resistant streptococcus pneumoniae]
Related Experiment Video
Updated: Aug 8, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Yukifusa Igeta1, Koji Ishiguro, Koichi Okamoto
1Maebashi Red Cross Hospital.
Abstract:
We report a patient of bacterial meningitis caused by penicillin-resistant streptococcus pneumoniae (PRSP). A 50-year-old Japanese man was admitted after developing a fever and quickly falling into unconsciousness. Neurological examination showed slightly consciousness disturbance and meningeal irritation. A lumbar puncture yielded turbid spinal fluid, with increased cell count (411/mm3), protein (685 mg/dl) and IgG (60.3 mg/dl) but decreased glucose (1 mg/dl). Bacterial meningitis was diagnosed and aminobenzylpenicillin (ABPC) and cefotaxime (CTX) were administered immediately, but they were ineffective. Penicillin-resistant streptcoccus pneumoniae (PRSP) was detected in the blood and spinal fluid, so antibiotics were changed to panipenem/betamipron (PAPM/BP) and vancomycin (VCM) with marked efficacy. With the increase in PRSP patients and documented failure in treatment of pneumococcal meningitis with ABPC and CTX, the need for alternative antibiotic therapy is critical. We emphasize the importance of initial therapy with PAPM/BP and VCM in patients with bacterial meningitis from streptcoccus pneumoniae.
Insights
This case study highlights a patient with bacterial meningitis caused by penicillin-resistant Streptococcus pneumoniae. Effective treatment required switching from initial antibiotics to panipenem/betamipron and vancomycin.
Area of Science:
- Infectious Diseases
- Microbiology
- Neurology
Background:
- Bacterial meningitis remains a critical global health concern, often caused by Streptococcus pneumoniae.
- Emergence of antibiotic resistance in bacterial pathogens poses significant challenges to effective treatment strategies.
Observation:
- A 50-year-old male presented with fever and altered consciousness, indicative of meningitis.
- Cerebrospinal fluid analysis revealed characteristic signs of bacterial meningitis, including elevated cell count, protein, and IgG, with decreased glucose.
- Initial treatment with aminobenzylpenicillin (ABPC) and cefotaxime (CTX) proved ineffective.
Findings:
- Penicillin-resistant Streptococcus pneumoniae (PRSP) was identified as the causative agent in both blood and cerebrospinal fluid.
- Switching antibiotic therapy to panipenem/betamipron (PAPM/BP) and vancomycin (VCM) resulted in a marked clinical improvement.
- This case underscores the treatment failures associated with conventional antibiotics like ABPC and CTX against PRSP.
Implications:
- The rising prevalence of PRSP necessitates a re-evaluation of standard antibiotic protocols for bacterial meningitis.
- Early consideration of potent broad-spectrum antibiotics such as PAPM/BP and VCM is crucial for managing suspected pneumococcal meningitis.
- This highlights the critical need for alternative therapeutic options and vigilant antibiotic stewardship in combating resistant bacterial infections.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis
Atypical Pneumonia
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Pneumonia I: Introduction

